万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>传染病学

Influenza and Other Respiratory Viruses《流感和其他呼吸道病毒》 (官网投稿)

简介
  • 期刊简称INFLUENZA OTHER RESP
  • 参考译名《流感和其他呼吸道病毒》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率6.90%
  • 主要研究方向医学-INFECTIOUS DISEASES 传染病学;VIROLOGY 病毒学

主要研究方向:

等待设置主要研究方向
医学-INFECTIOUS DISEASES 传染病学;VIROLOGY 病毒学

Influenza and Other Respiratory Viruses《流感和其他呼吸道病毒》(双月刊). Influenza and Other Respiratory Viruses is the first journal to specialise exclusi...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://onlinelibrary.wiley.com/journal/17502659

3、投稿网址:http://mc.manuscriptcentral.com/irv

4、官网邮箱:irv.eo@wiley.com

5、期刊刊期:双月刊,逢单月出版

2021年8月5日星期四

                                 

 

投稿须知【官网信息】

 

Influenza and Other Respiratory Viruses

Author Guidelines

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/irv

Click here for more details on how to use ScholarOne.

Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Influenza and Other Respiratory Viruses will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

Preprint your manuscript while it’s under review

Beginning in early 2020, Influenza and Other Respiratory Viruses is participating in a pilot of the under review service, Wiley’s new initiative to streamline the early sharing of research and open up the peer review process. Authors can now opt to preprint their manuscript during the submission process and showcase their work to the global research community as a preprint, before it is accepted or published.

The under review service is powered by Authorea, an open research platform for all your research outputs, including data, figures, and preprints. By opting-in authors can:

Seamlessly preprint at the same time you submit your research for publication 

Share your work early, while indicating it is being considered at a specific journal

Track the peer review process openly in real time

Immediately make their work citable, discoverable, and easily shareable

Get additional community feedback that can be used to improve your manuscript

Learn more about the benefits of the under review service.

For help with submissions, please contact:

Emily Mitic

Associate Managing Editor

irv.eo@wiley.com  

2. AIMS AND SCOPE

Influenza and Other Respiratory Viruses is the first journal to specialise exclusively on influenza and other respiratory viruses and strives to play a key role in the dissemination of information in this broad and challenging field. It is aimed at laboratory and clinical scientists, public health professionals, and others around the world involved in a broad range of activities in this field. In turn, topics covered will include:

surveillance

epidemiology

prevention by vaccines

prevention and treatment by antivirals

clinical studies

public health & pandemic preparedness

basic scientific research

transmission between animals and humans

The journal accepts papers dealing with human, zoonotic and potentially zoonotic respiratory virus infections and the editors will consider, on a case by case basis, papers reporting relevant animal models for these viruses.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

i. Review Article

Review articles, which must undergo peer review, will generally be commissioned, but non-commissioned reviews on timely subjects will be considered. Authors who would like to contribute review articles are encouraged to send a proposal to the Editors before submitting their full article.

Word limit: 5,000 words maximum, excluding abstract, references, tables, figures and legends.

Figures/Tables: Total of no more than 4 figures and tables.

Guidelines: Systematic reviews and meta-analyses should follow the PRISMA Statement, and a PRISMA checklist and flow diagram should be included in your submission. Prospective authors are also strongly encouraged to follow the guidance in the following article:

Wille-Jørgensen, P. and Renehan, A. G. (2008), Systematic reviews and meta-analyses in coloproctology: interpretation and potential pitfalls. Colorectal Disease, 10: 21–32. doi: 10.1111/j.1463-1318.2007.01421.x

ii. Original Article

Word limit: 5,000 words maximum (including tables, gures, and references).

Abstract: 250 words maximum, structured into the following sections: Background, Methods, Results and Conclusions.

iii. Letter to the Editor

Word limit: Should not normally exceed three typewritten pages.

Abstract: No abstract.

Figures/Tables: Total of no more than 1 figure or table.

Authors: Total of no more than 5 authors.

Letters to the Editor will be published free of charge.

iv. Short Communication

Word limit: 1,500 words maximum.

Abstract: A summary of up to 100 words should be followed by continuous text, subdivided if appropriate.

References: Maximum of 15 references.

Publication of initial results which will lead to more substantial papers will generally be discouraged.

4. PREPARING THE SUBMISSION

Free format submission

Influenza and Other Respiratory Viruses now offers free format submission for a simplified and streamlined submission process.

Before you submit, you will need:

Your manuscript: this can be a single file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers.

The title page of the manuscript, including statements relating to our ethics and integrity policies:

data availability statement

funding statement

conflict of interest disclosure

ethics approval statement

patient consent statement

permission to reproduce material from other sources

To submit, login at https://mc.manuscriptcentral.com/irv and create a new submission. Follow the submission steps as required and submit the manuscript.

If you are invited to revise your manuscript after peer review, the journal will request the revised manuscript to be formatted according to journal requirements as described below.

Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion.

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.

Main Text File

The text file should be presented in the following order:

i. A short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);

ii. A short running title of less than 50 characters;

iii. The full names of the authors;

iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;

v. Acknowledgments;

vi. Abstract and keywords;

vii. Main text;

viii. References;

ix. Tables (each table complete with title and footnotes);

x. Figure legends;

xi. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.

Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.

Author Contributions: For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract

Abstracts are required for some manuscript types. For details on manuscript types that require abstracts and/or keywords, as well as how to prepare them, please refer to the ‘Manuscript Types and Criteria’ section.

Keywords

Please provide 3-8 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/17502659/homepage/forauthors.html


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭